title: [Effect of prostaglandin El (alprostadil) on pulmonary hypertension in patients with chronic obstructive respiratory tract diseases (COPD)].
authors.forename: A
authors.initials: A
authors.lastname: Gassner
authors.forename: G
authors.initials: G
authors.lastname: Sommer
authors.forename: L
authors.initials: L
authors.lastname: Fridrich
authors.forename: D
authors.initials: D
authors.lastname: Magometschnigg
authors.forename: A
authors.initials: A
authors.lastname: Priol
mesh_terms: D000368:Aged; D000403:Airway Resistance / Q000187:drug effects; D000527:Alprostadil / Q000627:therapeutic use*; D002302:Cardiac Output / Q000187:drug effects; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000527:Alprostadil
vernacular_title: Der Einfluss von Prostaglandin E1 (Alprostadil) auf die pulmonale Hypertonie bei Patienten mit chronisch obstruktiven Atemwegserkrankungen (COPD).